Big Move For Hancock Jaffe Laboratories, Inc.
Thu, Jan 30, 2020 at 05:30 PM
Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ) shot up at $0.61, representing a gain of 20.4%. The stock got featured on our News Catalysts scanner on Wed 08 Jan 20 at 09:17 AM in the 'RECOMMENDATION' category. From Wed 08 Jan 20, the stock recorded 42.86% Up Days and 20.00% Green Days
About Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ)
Hancock Jaffe Laboratories Inc development stage medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal and peripheral arterial diseases in the United States and Europe.
Top 10 Gainers:
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 41.26%
- Sintx Technologies, Inc. (SINT:NASDAQ), 41.1%
- Advaxis, Inc. (ADXS:NASDAQ), 33.54%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 29.65%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 27.56%
- NanoViricides, Inc. (NNVC:NYSEMKT), 26.58%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 20.87%
- Lianluo Smart Limited (LLIT:NASDAQ), 20.83%
- Miragen Therapeutics, Inc. (MGEN:NASDAQ), 20.71%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 20.4%